3.3
Somministrazione di Farmaci: Panoramica
La selezione della via di somministrazione di un farmaco dipende dalle sue proprietà fisico-chimiche, tra cui la solubilità in lipidi o acqua e la ion…
La scelta della via di somministrazione di un farmaco dipende dalle sue caratteristiche fisico-chimiche, come la solubilità e la ionizzazione dei lipidi o dell'acqua, nonché dalle esigenze terapeutiche, come l'azione immediata o prolungata.
I farmaci possono essere somministrati per via enterale, parenterale e topica.
La via enterale è una via di somministrazione di farmaci comunemente usata, in cui un farmaco può essere deglutito direttamente, tenuto sotto la lingua o tra le gengive e le guance. I farmaci orali attraversano principalmente il tratto gastrointestinale per l'assorbimento sistemico.
La somministrazione enterale presenta degli svantaggi, tra cui scarso assorbimento, irritazione gastrica, instabilità del pH gastrico basso e metabolismo da parte della flora intestinale.
La via parenterale prevede l'iniezione di farmaci direttamente nel flusso sanguigno, nei muscoli o sotto la pelle, garantendo una biodisponibilità variabile.
Tra questi, la somministrazione endovenosa produce un'elevata biodisponibilità e una rapida insorgenza dell'azione.
La via topica prevede l'applicazione di farmaci direttamente sulla pelle o sulle mucose per un effetto localizzato con una tossicità minima.
View the full transcript and gain access to JoVE Core videos
Q1: What factors determine which drug delivery route to use?
Drug delivery route selection depends on the drug's physicochemical features, including lipid or water solubility and ionization, as well as therapeutic needs such as immediate or prolonged action. These factors determine whether enteral, parenteral, or topical administration is most appropriate for achieving desired therapeutic outcomes.
Q2: What are the main limitations of enteral drug delivery?
Enteral delivery has several drawbacks: poor absorption, gastric irritation, drug instability in low gastric pH, and metabolism by intestinal flora. However, most enteral drugs are designed with protective coatings and formulations to overcome these limitations and ultimately achieve good absorption in the gastrointestinal tract.
Q3: Why does intravenous administration provide faster drug effects than other routes?
Intravenous administration yields the highest bioavailability and fastest onset of action because drugs are injected directly into the bloodstream, bypassing absorption barriers. This parenteral route ensures rapid systemic distribution and therapeutic response compared to enteral routes that require gastrointestinal absorption and processing.
Q4: How do topical drugs achieve systemic effects?
While topical administration typically targets local effects on skin or mucous membranes with minimal toxicity, some drugs applied topically can achieve systemic effects. For example, transdermal fentanyl patches deliver drugs systemically over time through skin absorption into the bloodstream for widespread therapeutic distribution.
Q5: What are the different types of parenteral drug administration?
Parenteral delivery involves injecting drugs directly into the bloodstream, muscles, dermis, or subcutaneous tissue, providing varying degrees of bioavailability. Intravenous injection offers the highest bioavailability and fastest onset, while intramuscular and subcutaneous routes provide different absorption rates and therapeutic profiles for various clinical needs.
Q6: How do enteral drugs enter systemic circulation?
Orally administered drugs primarily traverse the gastrointestinal tract for systemic absorption. The drug must dissolve, be absorbed through the intestinal epithelium via mechanisms like paracellular transcellular and vesicular transport, and enter the bloodstream for distribution throughout the body and therapeutic action.
Q7: Why is drug formulation design important for enteral delivery?
Drug formulations are specifically designed to address enteral delivery challenges such as gastric degradation and poor absorption. Protective coatings limit drug degradation in the stomach's low pH environment, allowing drugs to reach the intestines intact for better systemic absorption and improved therapeutic efficacy.